• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The use of tissue plasminogen activator in post-traumatic total hyphaema.

作者信息

Laatikainen L, Mattila J

机构信息

Department of Opthalmology, Oulu University Hospital, Finland.

出版信息

Graefes Arch Clin Exp Ophthalmol. 1996 Jan;234(1):67-8. doi: 10.1007/BF00186522.

DOI:10.1007/BF00186522
PMID:8750854
Abstract

BACKGROUND

We wanted to evaluate whether intracameral injection of tissue plasminogen activator (tPA) is useful in managing traumatic hyphaema.

METHODS

Two eyes with total hyphaema after a severe penetrating injury were treated with a single intracameral injection of 25 micrograms of tPA 5 and 14 days after the injury, respectively.

RESULTS

Most of the blood coagulum dissolved within 24 h, and in one of the two eyes the intraocular pressure decreased from 45 to 8 mmHg. The other eye was hypotonic. No re-bleeding or complications related to the use of tPA were noticed.

CONCLUSION

The results in these two cases suggest that tPA is a useful adjunct in managing total hyphaema.

摘要

相似文献

1
The use of tissue plasminogen activator in post-traumatic total hyphaema.
Graefes Arch Clin Exp Ophthalmol. 1996 Jan;234(1):67-8. doi: 10.1007/BF00186522.
2
Intracameral tissue plasminogen activator use in a large series of eyes with valved glaucoma drainage implants.前房内组织型纤溶酶原激活剂在大量带瓣膜青光眼引流植入物眼内的应用。
Arch Ophthalmol. 2002 Nov;120(11):1487-93. doi: 10.1001/archopht.120.11.1487.
3
Low-dose intraocular tissue plasminogen activator treatment for traumatic total hyphema, postcataract, and penetrating keratoplasty fibrinous membranes.
J Cataract Refract Surg. 1995 Mar;21(2):219-24. doi: 10.1016/s0886-3350(13)80514-7.
4
Treatment of total hyphema with relatively low-dose tissue plasminogen activator.采用相对低剂量的组织型纤溶酶原激活剂治疗全前房积血。
Ophthalmic Surg Lasers. 1998 Sep;29(9):762-6.
5
Use of tissue plasminogen activator in experimental hyphema.组织型纤溶酶原激活剂在实验性前房积血中的应用。
Arch Ophthalmol. 1987 Jul;105(7):995-7. doi: 10.1001/archopht.1987.01060070139044.
6
Intracameral tissue plasminogen activator after glaucoma surgery. Indications, effectiveness, and complications.
Ophthalmology. 1996 Feb;103(2):274-82. doi: 10.1016/s0161-6420(96)30704-5.
7
Treatment of failing glaucoma filtering cystic blebs with tissue plasminogen activator (tPA).用组织纤溶酶原激活剂(tPA)治疗失败的青光眼滤过性囊肿性泡。
J Ocul Pharmacol Ther. 1995 Fall;11(3):227-32. doi: 10.1089/jop.1995.11.227.
8
Intracameral urokinase for dissolution of fibrin or blood clots after glaucoma surgery.前房内注射尿激酶用于青光眼手术后纤维蛋白或血凝块的溶解。
Am J Ophthalmol. 1997 Nov;124(5):693-5. doi: 10.1016/s0002-9394(14)70912-2.
9
Intraocular tissue plasminogen activator in a rabbit model of traumatic hyphema.眼内组织型纤溶酶原激活剂在兔外伤性前房积血模型中的应用
Arch Ophthalmol. 1991 Feb;109(2):272-4. doi: 10.1001/archopht.1991.01080020118055.
10
Intracameral tissue plasminogen activator to treat severe fibrinous effusion after cataract surgery.前房内注射组织型纤溶酶原激活剂治疗白内障术后严重纤维素性渗出物
J Cataract Refract Surg. 1997 Jul-Aug;23(6):873-7. doi: 10.1016/s0886-3350(97)80246-5.

引用本文的文献

1
Use of recombinant tissue plasminogen activator (rTPA) for treatment of fibrin in the anterior chamber of the horse.应用重组组织型纤溶酶原激活剂(rTPA)治疗马前房纤维蛋白。
Vet Med Sci. 2024 Jul;10(4):e1448. doi: 10.1002/vms3.1448.
2
Use of recombinant tissue plasminogen activator for treatment of recalcitrant anterior uveitis: A case series.重组组织型纤溶酶原激活剂用于治疗顽固性前葡萄膜炎:病例系列
J Taibah Univ Med Sci. 2018 Apr 6;13(5):483-487. doi: 10.1016/j.jtumed.2018.03.005. eCollection 2018 Oct.
3
Intracameral recombinant tissue plasminogen activator for refractory glaucoma secondary to a fungal corneal abscess.

本文引用的文献

1
The use of subconjunctivally administered tissue plasminogen activator after trabeculectomy.小梁切除术后结膜下注射组织型纤溶酶原激活剂的应用。
Ophthalmic Surg. 1994 Jan;25(1):51-3.
2
Intracameral tissue plasminogen activator to treat blocked glaucoma implants.前房内注射组织型纤溶酶原激活剂治疗青光眼植入物堵塞。
Ophthalmic Surg. 1993 Dec;24(12):854-5.
3
Intracameral tissue plasminogen activator: management of a fibrin clot occluding a Molteno tube.前房内组织型纤溶酶原激活剂:治疗阻塞莫尔顿引流管的纤维蛋白凝块
前房内注射重组组织型纤溶酶原激活剂治疗真菌性角膜溃疡继发难治性青光眼
Open Ophthalmol J. 2009 Sep 25;3:75-6. doi: 10.2174/1874364100903010075.
4
Observation on the effect of Salvia miltiorrhiza injection in treating traumatic hyphema and the opportune time for its application.丹参注射液治疗外伤性前房积血的疗效观察及用药时机
Chin J Integr Med. 2008 Sep;14(3):221-4. doi: 10.1007/s11655-008-0221-2. Epub 2008 Oct 14.
5
Intracameral tissue plasminogen activator to prevent severe fibrinous effusion after congenital cataract surgery.前房内注射组织型纤溶酶原激活剂预防先天性白内障手术后严重纤维蛋白性渗出
Br J Ophthalmol. 2005 Nov;89(11):1458-61. doi: 10.1136/bjo.2005.071407.
6
Recombinant tissue plasminogen activator following paediatric cataract surgery.小儿白内障手术后使用重组组织型纤溶酶原激活剂
Br J Ophthalmol. 2000 Sep;84(9):983-6. doi: 10.1136/bjo.84.9.983.
Ophthalmic Surg. 1993 Dec;24(12):853-4.
4
Tissue plasminogen activator treatment of postoperative intraocular fibrin.组织型纤溶酶原激活剂治疗术后眼内纤维蛋白。
Ophthalmology. 1988 May;95(5):592-6. doi: 10.1016/s0161-6420(88)33140-4.
5
Treatment of postvitrectomy fibrin formation with intraocular tissue plasminogen activator.
Arch Ophthalmol. 1988 Aug;106(8):1055-8. doi: 10.1001/archopht.1988.01060140211025.
6
Use of tissue plasminogen activator in experimental hyphema.组织型纤溶酶原激活剂在实验性前房积血中的应用。
Arch Ophthalmol. 1987 Jul;105(7):995-7. doi: 10.1001/archopht.1987.01060070139044.
7
Tissue plasminogen activator and the corneal endothelium.组织型纤溶酶原激活剂与角膜内皮
Am J Ophthalmol. 1989 Jul 15;108(1):91-2. doi: 10.1016/s0002-9394(14)73273-8.
8
Rebleeding in experimental traumatic hyphema treated with intraocular tissue plasminogen activator.眼内注射组织型纤溶酶原激活剂治疗实验性外伤性前房积血的再出血情况
Arch Ophthalmol. 1990 Feb;108(2):264-6. doi: 10.1001/archopht.1990.01070040116043.
9
Retinal toxicity of recombinant tissue plasminogen activator in the rabbit.
Arch Ophthalmol. 1990 Feb;108(2):259-63. doi: 10.1001/archopht.1990.01070040111042.
10
Tissue plasminogen activating factor assisted removal of subretinal hemorrhage.
Ophthalmic Surg. 1991 Oct;22(10):575-82.